Identifiable and Unidentifiable Factors Influencing Lymph Node Examination and Adjuvant Chemotherapy in Stage I Lung Cancer

Affiliations

¹ Department of Thoracic Surgery, Shanghai Pulmonary Hospital Tongji University, Shanghai, People's Republic of China.
² Department of Thoracic Surgery, Shanghai Pulmonary Hospital Tongji University, Shanghai, People's Republic of China. Electronic address: zhangpeng1121@tongji.edu.cn.

Free article

Comment

Jie Dai et al. J Thorac Oncol. 2020 May.

Free article

. 2020 May;15(5):e78-e79.

doi: 10.1016/j.jtho.2020.02.016.

¹ Department of Thoracic Surgery, Shanghai Pulmonary Hospital Tongji University, Shanghai, People's Republic of China.
² Department of Thoracic Surgery, Shanghai Pulmonary Hospital Tongji University, Shanghai, People's Republic of China. Electronic address: zhangpeng1121@tongji.edu.cn.

No abstract available

Comment on

Optimal Lymph Node Examination and Adjuvant Chemotherapy for Stage I Lung Cancer.
Dai J, Liu M, Yang Y, Li Q, Song N, Rocco G, Sihoe ADL, Gonzalez-Rivas D, Suen HC, He W, Duan L, Fan J, Zhao D, Wang H, Zhu Y, Chen C, Diasio RB, Jiang G, Yang P, Zhang P. Dai J, et al. J Thorac Oncol. 2019 Jul;14(7):1277-1285. doi: 10.1016/j.jtho.2019.03.027. Epub 2019 Apr 19. J Thorac Oncol. 2019. PMID: 31009811
Evaluated Lymph Node Number in Population-Based Analyses: Significant Prognostic Factor, but Assess With Caution.
Wo Y, Wang Y, Lu T, Sun D, Jiao W. Wo Y, et al. J Thorac Oncol. 2020 May;15(5):e77-e78. doi: 10.1016/j.jtho.2020.02.015. J Thorac Oncol. 2020. PMID: 32340683 No abstract available.